» Articles » PMID: 29805578

Long Non-coding RNA Regulates Viability and Metastasis, and is Upregulated in Retinoblastoma

Overview
Journal Oncol Lett
Specialty Oncology
Date 2018 May 29
PMID 29805578
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Retinoblastoma is the most common type of intraocular pediatric malignant tumor, which typically affects children <6 years of age. However, the underlying molecular mechanisms of retinoblastoma progression remain unclear. The aim of the present study was to investigate the function of long non-coding RNA (lncRNA) in retinoblastoma clinical samples and cell lines, using reverse transcription-quantitative polymerase chain reaction, western blotting, colony formation, MTT, fluorescence activated cell sorting, cell invasion and migration, and growth assays. The results demonstrated that may serve a critical oncogenic function in the progression of retinoblastoma, as lncRNA levels were markedly increased in retinoblastoma cells and tissues compared with corresponding controls. In addition, patients with retinoblastoma with increased lncRNA expression experienced poorer survival time compared with those with decreased lncRNA levels. Knockdown of lncRNA significantly suppressed retinoblastoma cell proliferation, migration and invasion and . Furthermore, lncRNA expression was also associated with multiple proteins, including cyclin-dependent kinase 1, B-cell lymphoma-associated X protein, apoptosis regulator, tumor protein p53, vimentin, cadherin 13 and matrix metallopeptidase 9. In conclusion, lncRNA may serve an important function in tumorigenesis and may be a potential target for therapy and prognosis in retinoblastoma.

Citing Articles

Applications of Non-Coding RNAs in Patients With Retinoblastoma.

Fernandez-Diaz D, Rodriguez-Vidal C, Silva-Rodriguez P, Paniagua L, Blanco-Teijeiro M, Pardo M Front Genet. 2022; 13:842509.

PMID: 35432447 PMC: 9008704. DOI: 10.3389/fgene.2022.842509.


LncRNA H19: A novel oncogene in multiple cancers.

Yang J, Qi M, Fei X, Wang X, Wang K Int J Biol Sci. 2021; 17(12):3188-3208.

PMID: 34421359 PMC: 8375239. DOI: 10.7150/ijbs.62573.


Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis.

Wu J, Qian D, Sun X Cancer Cell Int. 2020; 20:201.

PMID: 32514246 PMC: 7257223. DOI: 10.1186/s12935-020-01281-0.


XIST promotes cell proliferation and invasion by regulating miR-140-5p and SOX4 in retinoblastoma.

Wang Y, Sun D, Sheng Y, Guo H, Meng F, Song T World J Surg Oncol. 2020; 18(1):49.

PMID: 32127028 PMC: 7055023. DOI: 10.1186/s12957-020-01825-8.


Extracellular Vesicles in Epstein-Barr Virus Pathogenesis.

Cone A, York S, Meckes Jr D Curr Clin Microbiol Rep. 2020; 6(3):121-131.

PMID: 32051811 PMC: 7015464. DOI: 10.1007/s40588-019-00123-6.


References
1.
Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, Mori M . Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res. 2008; 14(8):2334-40. DOI: 10.1158/1078-0432.CCR-07-4667. View

2.
Lin P, OBrien J . Frontiers in the management of retinoblastoma. Am J Ophthalmol. 2009; 148(2):192-8. DOI: 10.1016/j.ajo.2009.04.004. View

3.
Liang W, Fu W, Wong C, Wang Y, Wang W, Hu G . The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 2015; 6(26):22513-25. PMC: 4673179. DOI: 10.18632/oncotarget.4154. View

4.
Carninci P, Kasukawa T, Katayama S, Gough J, Frith M, Maeda N . The transcriptional landscape of the mammalian genome. Science. 2005; 309(5740):1559-63. DOI: 10.1126/science.1112014. View

5.
Matouk I, Raveh E, Abu-Lail R, Mezan S, Gilon M, Gershtain E . Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta. 2014; 1843(7):1414-26. DOI: 10.1016/j.bbamcr.2014.03.023. View